ALNY vs FCF · P/E 76, rev $1.29B vs P/E 13, rev $316.5M
Alnylam Pharmaceuticals Inc (ALNY) versus First Commonwealth Financial (FCF) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
First Commonwealth Financial (FCF) is a banks - regional company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported FCF revenue for 2026-06-30 was $316.5M. Net income was $82.1M. FCF currently screens at market cap $1.94B and trailing P/E 12.6.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. FCF currently screens at market cap $1.94B and trailing P/E 12.6.
Not investment advice. Open the ALNY and FCF stock pages for the full models.
Not investment advice.